CN Patent

CN119730839A — 稳定的肽组合物及使用其治疗中/重度干眼相关的眼部症状的方法

Assigned to Tearsolutions Inc · Expires 2025-03-28 · 1y expired

What this patent protects

本申请总体上涉及包含低水平的缓冲剂和螯合剂的稳定的肽组合物和套装产品，以及使用它们治疗患有中/重度或重度干眼的患者的方法。

USPTO Abstract

本申请总体上涉及包含低水平的缓冲剂和螯合剂的稳定的肽组合物和套装产品，以及使用它们治疗患有中/重度或重度干眼的患者的方法。

Drugs covered by this patent

articaine-hydrochloride (ARTICAINE HYDROCHLORIDE)

Patent Metadata

Patent number: CN119730839A
Jurisdiction: CN
Classification: —
Expires: 2025-03-28
Drug substance claim: No
Drug product claim: No
Assignee: Tearsolutions Inc
Source: FDA Orange Book + USPTO grounding via Google Patents

Bibliographic data sourced from FDA Orange Book + USPTO public records. Plain-English summary generated by AI grounded in source text. Patent term extensions (PTR, SPC, pediatric) may shift the effective expiry. Not legal advice.

Track this patent

Get a daily-checked alert when vulnerability score, expiry, classification, or assignee changes. Email, Slack, or Teams delivery. Pro: 50 watches, Free: 3.